Previous 10 | Next 10 |
ORLANDO, Fla., Jan. 17, 2020 (GLOBE NEWSWIRE) -- It doesn’t take an analyst to suggest that high value merger and acquisition activity in any industry is a bullish sign. And it assuredly doesn’t take any research firm at all to suggest that an eczema related company like Hoth...
Hoth Therapeutics (NASDAQ: HOTH ) has exercised its option to take an exclusive license for patents owned by the George Washington University (GW). More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...
ORLANDO, Fla., Jan. 14, 2020 (GLOBE NEWSWIRE) -- The headline of our written offering today probably appears a little different from our regular titles. Typically we don’t lead with things that are so widely despised or feared. But when we are discussing biopharmaceutical company Ho...
ORLANDO, Fla., Dec. 23, 2019 (GLOBE NEWSWIRE) -- As the holidays roll into November and December many companies go quietly into the New Year, eschewing news releases or large scale investor communication. That has definitely not been the case for Hoth Therapeutics, Inc. (NASDAQ: HOTH) - a...
NEW YORK , Dec. 23, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological and immunological disorders such as atopic dermatitis, psoriasis, asthma and acne, today...
NEW YORK , Dec. 19, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today anno...
NEW YORK , Dec. 17, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today ann...
ORLANDO, Fla., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Nearly every person suffering from atopic dermatitis, more popularly known as “eczema,” knows just how difficult it can be to find effective remedies for his or her condition. Many prescription and over-the-counter treatments ar...
PHILADELPHIA, PA / ACCESSWIRE / December 11, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), will be presenting at this year's Investor Summit on December 17 th in Philadelphia. The Investor Summit will take place at Hotel Monaco, featuring 30 companies and over 200 institutional and retail ...
NEW YORK , Dec. 9, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, is pleased to an...
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NASDAQ Market:
Hoth Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire Treatment of pre-clinical subjects showed cognitive benefits that suggest HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitiv...